Capstan Therapeutics
PrivateLast Round
Series B
3/20/2024
Est. Valuation
$500M
Total Funding Raised
$340M
Company Overview
Capstan Therapeutics is a biotechnology company focused on enhancing the therapeutic potential of in vivo RNA-based therapies through innovative targeted delivery systems.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Advanced Materials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Capstan Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Capstan Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | 3/20/2024 | ||||
| Series A | 9/14/2022 | ||||
| Seed | 11/24/2021 |
Capstan Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion Capital Partners | Series B |
| RA Capital Management | Seed, Series A, Series B |
| Perceptive Advisors | Series B |
| Vida Ventures | Series B, Seed, Series A |
| OrbiMed | Series B, Seed, Series A |
| Novartis Venture Fund | Series A, Seed, Series B |
| Pfizer Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2025
AbbVie is acquiring the company, a rapid windfall for the startup.
- Jun 24, 2025
Nanna Luneborg joins the board of directors.
Capstan Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Capstan Therapeutics's valuation, stock price, and market status.
